Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports

Intravenous enzyme replacement therapy is a first-line therapy for Gaucher disease type 1, and substrate reduction therapy represents an oral treatment alternative. Both enzyme replacement therapy and substrat...

http://ift.tt/2ngBRHe